TickerFacts.

Dianthus Therapeutics, Inc. (DNTH): Shareholders' Equity

Annual figures by period end, from SEC filings.

$493.40M
As of 2025-12-31
$1.17B
As of 2026-06-30
+27.9%
5-year compound annual growth
2016-12-31: -$8.87M2017-12-31: -$42.12M2018-12-31: $145.65M2019-12-31: $141.19M2020-12-31: $143.91M2021-12-31: $172.67M2022-12-31: -$44.37M2023-12-31: $168.87M2024-12-31: $352.48M2025-12-31: $493.40M$493.40M
2016-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$493.40M+40.0%2026-03-09, Balance as of period end
2024-12-31$352.48M+108.7%2026-03-09, Balance as of period end
2023-12-31$168.87Mn/m2025-03-11, Balance as of period end
2022-12-31-$44.37Mn/m2024-03-21, Balance as of period end
2021-12-31$172.67M+20.0%2023-03-23, Balance as of period end
2020-12-31$143.91M+1.9%2022-03-08, Balance as of period end
2019-12-31$141.19M-3.1%2021-03-03, Balance as of period end
2018-12-31$145.65Mn/m2020-03-03, Balance as of period end
2017-12-31-$42.12Mn/m2020-03-03, Balance as of period end
2016-12-31-$8.87Mn/a2019-03-19, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Dianthus Therapeutics, Inc. (DNTH)2025-12-31$493.40M+40.0%
Korsana Biosciences, Inc. (KRSA)2025-12-31$9.09M+2.7%
Lipocine Inc. (LPCN)2025-12-31$14.48M-31.1%
Bio Essence Corp (BIOE)2025-12-31-$2.07Mn/m
GeoVax Labs, Inc. (GOVX)2025-12-31$3.83M-24.2%
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31$33.01Mn/m
Cartesian Therapeutics, Inc. (RNAC)2025-12-31-$126.24Mn/m
Upstream Bio, Inc. (UPB)2025-12-31$339.77M-27.7%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31-$15.94Mn/m

Compare DNTH, KRSA, LPCN, BIOE side by side · Screen every company in Pharmaceutical Preparations ↗